Becky Gamliel

Smart Assays has been a key factor in the regulatory submissions and financing rounds of public and private life science companies,  providing hands-on expertise and tailor-made R&D services for the evaluation and validation of early and clinical-stage projects. Smart Assays reflects a unique work model – a combination of proficiency in analytical chemistry and biochemical processes, provided by a skilled, creative team with extensive and cumulative scientific knowledge and a proven track record in assay development, drug discovery, MOA, and POC studies, research histopathology and bioanalytic research. Established in 2005, Smart Assays operates in a 350m² state-of-the-art facility situated in the Weizmann Science Park in the heart of Israel’s entrepreneurial Life Science and Biotech ecosystem.​ Located at the heart of the Weizmann Technology Park, Smart Assays works in close collaboration with its clients and complete transparency: all knowhow and work protocols created during projects, are our clients' property and enhance their core knowledge. Smart Assays performs traditional methodologies with precision and profound scientific understanding. It provides original solutions where traditional methodologies fail. Smart Assays highly trained, creative scientists and strong project management approach, together with its state-of-the-art laboratories, provides the services that get their clients to the next level.